AGX Financials

Income Statement
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026
Revenue
291.0M
+11.0%
262.1M
+4.3%
251.2M
+5.6%
237.7M
+22.8%
193.7M
Cost of Revenue
229.8M
+17.0%
196.5M
-3.8%
204.2M
+5.5%
193.5M
+23.4%
156.8M
Gross Profit
61.1M
-6.8%
65.6M
+39.7%
46.9M
+6.1%
44.3M
+20.1%
36.9M
Operating Expenses
15.7M
-12.3%
17.9M
+25.2%
14.3M
+0.7%
14.2M
+13.5%
12.5M
R&D
0
0
0
0
0
SG&A
15.7M
-12.3%
17.9M
+25.2%
14.3M
+0.7%
14.2M
+13.5%
12.5M
Operating Income
45.4M
-4.8%
47.7M
+46.1%
32.6M
+8.6%
30.1M
+23.5%
24.3M
EBITDA
46.0M
-4.6%
48.2M
+45.4%
33.1M
+8.5%
30.5M
+23.4%
24.8M
Net Income
46.1M
-6.4%
49.2M
+60.1%
30.7M
-12.9%
35.3M
+56.4%
22.6M
EPS (Basic)
$3.30
-6.8%
$3.54
+59.5%
$2.22
-13.6%
$2.57
+55.8%
$1.65
EPS (Diluted)
$3.24
-6.6%
$3.47
+59.9%
$2.17
-13.2%
$2.50
+56.2%
$1.60
Shares (Diluted)
14.2M
+0.1%
14.2M
+0.2%
14.2M
+0.2%
14.1M
+0.1%
14.1M
Argan (AGX) โ€” Financials